diabetic kidney disease

Advertisement
Ajay K. Singh, MBBS, FRCP, MBANKF Spring Clinical Meetings 2024 | May 29, 2024
Ajay K. Singh discussed his findings on daprodustat dosing and utilization of finerenone.
View More
Victoria SochaDiabetes and Hypertension | May 14, 2024
Could urinary podocyte stress biomarker be a surrogate marker of podocyte injury in diabetic kidney disease (DKD)?
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD).
Victoria SochaKidney Transplantation | February 5, 2024
The most common primary renal disease in patients initiating renal replacement therapy is diabetes.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Several classes of glucose-lowering drugs have been shown to have kidney benefits in patients with type 2 diabetes.
Victoria SochaDiabetes and Hypertension | February 5, 2024
The most common concomitant medication classes were antihypertensives (95%), antihyperglycemic (81%), and statins (79%).
Victoria SochaDiabetes and Hypertension | February 5, 2024
Preliminary evidence has demonstrated preservation of kidney function as measured by eGFR compared with baseline.
Victoria SochaHyperkalemia | February 5, 2024
There was a five-fold higher risk of hyperkalemia with use of a steroidal MRA plus an ACEi or ARB.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Assessing the early impact of risk categorization on management of patients with DKD.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Gaps in care in treating proteinuria in patients with DKD.
Victoria SochaNephrology Times | February 5, 2024
In the population of patients with chronic kidney disease (CKD), particularly those with diabetes as the underlying ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
In patients with type 2 diabetes, ectopic fat is a major pathogenic factor. According to Niels Sondergaard Heinrich, MD, ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Nonalbuminuric diabetic kidney disease (DKD) has become the prevailing phenotype of DKD. Qiao Jin, MSc, and colleagues, ...
Victoria SochaChronic Kidney Disease | February 5, 2024
According to Mukoso N. Ozieh, MD, and Leonard E. Egede, MD, MS, of the Medical College of Wisconsin, behavioral factors, ...
Victoria SochaNational Kidney Foundation 2022 | February 5, 2024
FIDELITY, a prespecified pooled analysis of results from the phase 3 FIDELIO-DKD and FIGARO-DKD trials, demonstrated ...
Victoria SochaChronic Kidney Disease | February 5, 2024
Patient education is a component of prevention of progression of kidney disease. Paul Flynn and colleagues at SUNY ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Clinical trials in nephrology are enriched for patients with micro- or macroalbuminuria to enroll patients at risk of ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Among obese patients with type 2 diabetes, hyperfiltration is a risk factor for accelerated decline in glomerular ...
Victoria SochaDiabetes and Hypertension | February 5, 2024
Worldwide, the prevalence of end-stage kidney disease (ESKD) is increasing; the leading cause of ESKD is diabetes. The ...
Advertisement
Advertisement
Advertisement
Latest News

July 26, 2024